JPMorgan Chase & Co’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
54,094
-68,088
| -56% | -$1.77M | ﹤0.01% | 3542 |
|
|
2025
Q1 | $2.99M | Sell |
122,182
-46,684
| -28% | -$1.14M | ﹤0.01% | 3014 |
|
|
2024
Q4 | $4.84M | Buy |
168,866
+137,795
| +443% | +$3.95M | ﹤0.01% | 2770 |
|
|
2024
Q3 | $1.17M | Buy |
31,071
+11,542
| +59% | +$435K | ﹤0.01% | 3559 |
|
|
2024
Q2 | $617K | Buy |
19,529
+9,991
| +105% | +$315K | ﹤0.01% | 3750 |
|
|
2024
Q1 | $419K | Buy |
+9,538
| New | +$419K | ﹤0.01% | 4060 |
|